1. Home
  2. PGEN vs USAS Comparison

PGEN vs USAS Comparison

Compare PGEN & USAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PGEN
  • USAS
  • Stock Information
  • Founded
  • PGEN 1998
  • USAS 1998
  • Country
  • PGEN United States
  • USAS Canada
  • Employees
  • PGEN N/A
  • USAS N/A
  • Industry
  • PGEN Biotechnology: Pharmaceutical Preparations
  • USAS Metal Mining
  • Sector
  • PGEN Health Care
  • USAS Basic Materials
  • Exchange
  • PGEN Nasdaq
  • USAS Nasdaq
  • Market Cap
  • PGEN 344.0M
  • USAS 286.7M
  • IPO Year
  • PGEN N/A
  • USAS N/A
  • Fundamental
  • Price
  • PGEN $1.53
  • USAS $0.61
  • Analyst Decision
  • PGEN Strong Buy
  • USAS Strong Buy
  • Analyst Count
  • PGEN 4
  • USAS 1
  • Target Price
  • PGEN $7.33
  • USAS $1.00
  • AVG Volume (30 Days)
  • PGEN 1.4M
  • USAS 1.4M
  • Earning Date
  • PGEN 05-13-2025
  • USAS 05-14-2025
  • Dividend Yield
  • PGEN N/A
  • USAS N/A
  • EPS Growth
  • PGEN N/A
  • USAS N/A
  • EPS
  • PGEN N/A
  • USAS N/A
  • Revenue
  • PGEN $3,925,000.00
  • USAS $100,188,000.00
  • Revenue This Year
  • PGEN $189.12
  • USAS $59.01
  • Revenue Next Year
  • PGEN $1,093.07
  • USAS $8.16
  • P/E Ratio
  • PGEN N/A
  • USAS N/A
  • Revenue Growth
  • PGEN N/A
  • USAS 18.02
  • 52 Week Low
  • PGEN $0.65
  • USAS $0.21
  • 52 Week High
  • PGEN $2.17
  • USAS $0.65
  • Technical
  • Relative Strength Index (RSI)
  • PGEN 52.21
  • USAS 62.86
  • Support Level
  • PGEN $1.33
  • USAS $0.40
  • Resistance Level
  • PGEN $1.49
  • USAS $0.65
  • Average True Range (ATR)
  • PGEN 0.14
  • USAS 0.06
  • MACD
  • PGEN 0.02
  • USAS 0.01
  • Stochastic Oscillator
  • PGEN 95.45
  • USAS 81.37

About PGEN Precigen Inc.

Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.

About USAS Americas Gold and Silver Corporation no par value

Americas Gold And Silver Corp is a mining company engaged in the acquisition, exploration, development, and production of precious metals mineral properties in Mexico and the United States. The company's primary operating assets are The Cosala operations, The Galena Complex, and Relief Canyon. The company also holds interests in the San Felipe Development Project located in Sonora, Mexico. It has geographic focus is the Western Hemisphere, particularly the United States and Mexico.

Share on Social Networks: